Comparing Safety and Effectiveness of Pill vs. Vaginal Medication for Labor Induction at Full Term
Phase 4
- Conditions
- Health Condition 1: O610- Failed medical induction of labor
- Registration Number
- CTRI/2024/04/065173
- Lead Sponsor
- JAWAHAR LAL NEHRU MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Live singleton pregnancy of gestational age of 37–42 weeks.
Multiparous women.
A cephalic presentation.
Post dated pregnancy.
Premature rupture of membranes.
Bishop score <6.
Reactive Non Stress test
Clinically adequate pelvis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mode of delivery <br/ ><br>Induction-to-delivery interval in vaginal delivery <br/ ><br>Vaginal delivery within 24 hours. <br/ ><br>Timepoint: 24 HOURS <br/ ><br>
- Secondary Outcome Measures
Name Time Method umber of doses of misoprostol needed to effect vaginal delivery <br/ ><br>Augmentation with oxytocin <br/ ><br>Incidence of failed induction <br/ ><br>Maternal adverse effects (nausea/vomiting, diarrhea, fever, postpartum hemorrhage, uterine rupture) <br/ ><br>Neonatal outcomes. <br/ ><br> <br/ ><br>Timepoint: 24 HOURS